Study To Evaluate The Efficacy And Safety Of Balovaptan In Adults With Post-Traumatic Stress Disorder (PTSD)

NCT05401565 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Stress Disorders, Post-Traumatic

Interventions

DRUG: Balovaptan
DRUG: Placebo

Sponsor

Hoffmann-La Roche